Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Maier-Dobersberger, T.
space
  arrow  Gangl, A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Detection of the His1069Gln Mutation in Wilson Disease by Rapid Polymerase Chain Reaction

right arrow Theresia Maier-Dobersberger, MD; Peter Ferenci, MD; Claudia Polli; Pauline Balac, PhD; Hans Peter Dienes, MD; Klaus Kaserer, MD; Christian Datz, MD; Wolfgang Vogel, MD; and Alfred Gangl, MD

1 July 1997 | Volume 127 Issue 1 | Pages 21-26

Background: Most known mutations in the gene associated with Wilson disease are rare. Only the His 1069Gln mutation is found often in patients of Northern or Eastern European origin.

Objective: To examine the frequency of the His 1069Gln mutation in Austrian patients with Wilson disease and their families by using a new, rapid polymerase chain reaction (PCR) test.

Design: Cross-sectional study.

Setting: University medical center.

Patients: 83 patients from 72 families and 98 relatives of 11 homozygous index patients.

Measurements: Results of a semi-nested PCR-based assay to detect the His 1069Gln mutation in Wilson disease, clinical symptoms, and liver histologic findings.

Results: 20 patients, including 5 siblings, were homozygous for the His1069Gln mutation. Thirty-three patients, including 4 siblings, were compound heterozygotes. The mutation was not detected in 30 patients, including 2 siblings. Homozygotes were older at onset of symptoms (mean age, 24 ± 6 years) than compound heterozygotes (17 ± 6 years [95% CI, 3.3 to 10.7 years]; P = 0.0135) and patients with other mutations (18 ± 8 years [CI, 1.8 to 10.2 years]; P = 0.117). Homozygotes were more often female (73.3%) than were compound heterozygotes (48% [CI, 0.94% to 2.46%]) and patients with other mutations (50% [CI, 0.91% to 2.37%]) (P = 0.05). Four of 98 asymptomatic relatives of 11 homozygous index patients were also homozygotes. Heterozygosity was confirmed in 46 relatives (19 parents, 11 children, and 16 distant relatives).

Conclusion: The His 1069Gln mutation was detected in 61% of Austrian patients with Wilson disease. Polymerase chain reaction may be useful for diagnosis and screening of family members of homozygous index patients, even if first-degree relatives are not available for examination.

Author and Article Information
space

From University of Vienna, Vienna, Austria: University of Sheffield, Sheffield, United Kingdom; University of Cologne, Cologne, Germany; General Hospital of Salzburg, Salzburg, Austria; and University of Innsbruck, Innsbruck, Austria.
Acknowledgments: The authors thank the members of the families who participated in the study; Drs. Gerhard Granditsch, Bruno Schneewei ß, Kurt Erhart, Jozef Holoman, Felix Stockenhuber, Rudolf Stauber, Aniko Somogyi, and Christa Binder for allowing us to examine their patients and providing clinical information; Dr. Edmund Cauza for help in collecting blood samples; and Mr. Cyrus Yeganehfar for technical help.
Grant Support: In part by the Medizinisch-wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien.
Requests for Reprints: Theresia Maier-Dobersberger, MD, Department of Internal Medicine IV, Gastroenterology and Hepatology, University of Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
Current Author Addresses: Drs. Maier-Dobersberger, Ferenci, and Gangl and Ms. Polli: Department of Internal Medicine IV, Gastroenterology and Hepatology, University of Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.




This article has been cited by other articles:


Home page
J. Med. Genet.Home page
P de Bie, P Muller, C Wijmenga, and L W J Klomp
Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes
J. Med. Genet., November 1, 2007; 44(11): 673 - 688.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
U Merle, M Schaefer, P Ferenci, and W Stremmel
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study
Gut, January 1, 2007; 56(1): 115 - 120.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
L.K. Prashanth, A.B. Taly, S. Sinha, S. Ravishankar, G.R. Arunodaya, M.K. Vasudev, and H.S. Swamy
Prognostic factors in patients presenting with severe neurological forms of Wilson's disease
QJM, August 1, 2005; 98(8): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Schiefermeier, H. Kollegger, C. Madl, C. Polli, W. Oder, H.-J. Kuhn, F. Berr, and P. Ferenci
The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease
Brain, March 1, 2000; 123(3): 585 - 590.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1997 by the American College of Physicians.